Article
Interleukin-7 and soluble Interleukin-7 receptor levels in type 1 diabetes - Impact of IL7RA polymorphisms, HLA risk genotypes and clinical features.
Clinical immunology (Orlando, Fla.) - 1 Feb 2022
Hoffmann Maximilian, Enczmann Jürgen, Balz Vera, Kummer Sebastian, Reinauer Christina, Döing Carsten, Förtsch Katharina, Welters Alena, Kohns Vasconcelos Malte, Mayatepek Ertan, Meissner Thomas, Jacobsen Marc, Seyfarth Julia
Abstract excerpt
High soluble IL-7 receptor (sIL-7R) serum levels and associated single nucleotide polymorphisms in the IL7RA gene were found in autoimmune diseases including type 1 diabetes. Further determinants on sIL-7R and IL-7 availability as well as changes during type 1 diabetes disease course remain elusive. Here we performed multiparameter analysis to identify influential genetic and disease-associated factors on sIL-7R...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
